Robotic surgery for colorectal liver metastases resection: A systematic review

Background The role of robotic surgery for colorectal cancer liver metastases (CRCLMs) has never been investigated in large series. Methods A systematic literature review was carried out on PubMed and Cochrane libraries. Results We selected nine studies between 2008 and 2021. Two hundred sixty‐two p...

Full description

Saved in:
Bibliographic Details
Published inThe international journal of medical robotics + computer assisted surgery Vol. 17; no. 6; pp. e2330 - n/a
Main Authors Rocca, Aldo, Scacchi, Andrea, Cappuccio, Micaela, Avella, Pasquale, Bugiantella, Walter, De Rosa, Michele, Costa, Gianluca, Polistena, Andrea, Codacci‐Pisanelli, Massimo, Amato, Bruno, Carbone, Fabio, Ceccarelli, Graziano
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.12.2021
Subjects
CAS
Colorectal cancer
colorectal liver metastases
Colorectal Neoplasms - surgery
Computer assisted surgery
Hepatectomy
Humans
Laparoscopy
Length of Stay
Literature reviews
Liver
Liver Neoplasms - surgery
Metastasis
Postoperative Complications
Robotic surgery
Robotic Surgical Procedures
Survival
Systematic review
systematic review
colorectal liver metastases
robotic surgery
Online AccessGet full text

Cover

More Information
Summary:Background The role of robotic surgery for colorectal cancer liver metastases (CRCLMs) has never been investigated in large series. Methods A systematic literature review was carried out on PubMed and Cochrane libraries. Results We selected nine studies between 2008 and 2021. Two hundred sixty‐two patients were included. One hundred thirty‐one patients underwent simultaneous resections. The mean blood loss was 309.4 ml (range, 200‐450 ml), the mean operative time was 250.5 min (range, 198.5‐449.0 min). The mean length of hospital stay was 7.98 days (range, 4.5 to 12 days). The overall postoperative mortality was 0.4%. The overall morbidity rate was 37.0%, Clavien‐Dindo grade III‐IV complications were 8.4%. The mean 3‐year overall survival was 55.25% (range, 44.4‐66.1%), the mean 3‐year disease free survival was 37% (range, 33.3‐41.9%) Conclusion We can conclude that robotic‐assisted surgery might be considered as a technical upgrade option for minimally invasive approach to CRCLM resections even for simultaneous operations and challenging cases.
Bibliography:Andrea Scacchi and Micaela Cappuccio have equally contributed to the paper.
ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
ISSN:1478-5951
1478-596X
1478-596X
DOI:10.1002/rcs.2330